Clinical trial · Interventional
Efficacy and Safety of TORS for SCCA
A Single Arm Study of Efficacy and Functional Quality of Life in Patients Treated With Transoral Robotic Surgery for Oropharyngeal and Supraglottic Squamous Cell Carcinoma
NCT01819480CI-TRIAL-00073870unknownN/AClinicalTrials.gov clinicaltrialsProvenance
- Source
- ClinicalTrials.gov
- Retrieved
- Sep 8, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Run
- ING-CLINICALTRIALS-20260908-000001
Summary
Brief summary (as posted)
The purpose of this study is to learn more about the outcomes of treatment of throat and voice box cancers using transoral robotic surgery (TORS). TORS is a relatively new option involving the use of the da Vinci surgical robot to remove these cancers through the mouth.
Conditions
Conditions (2)
Free-text conditions as registered, with the CancerIndex entity they were reconciled to and the match type.
| Condition (as posted) | Mapped entity | Match | Confidence |
|---|---|---|---|
| Oropharyngeal Squamous Cell Carcinoma | Oropharyngeal Squamous Cell Carcinoma | ONTOLOGY_EXACT | 0.98 |
| Supraglottic Squamous Cell Carcinoma | Supraglottic Squamous Cell Carcinoma | ONTOLOGY_EXACT | 0.98 |
Interventions
Interventions (1)
| Intervention | Type | Mapped drug | Match |
|---|---|---|---|
| Transoral robotic surgery | Procedure | — | UNRESOLVED |
Design
Arms and outcomes
Arms (1)
- type
- EXPERIMENTAL
- label
- Transoral robotic surgery
- description
- Transoral robotic surgery
- interventionNames
- Procedure: Transoral robotic surgery
Primary outcomes (1)
- measure
- Progression-free survival
- timeFrame
- 3 years
- description
- Duration of time from date of surgery to date of recurrence or death
Secondary outcomes (1)
- measure
- Disease specific survival
- timeFrame
- 3 years
- description
- Duration of time from the date of surgery until death with disease present
Eligibility
Eligibility (as posted)
- Sex
- All
- Minimum age
- 18 Years
Show eligibility criteria text
Inclusion Criteria: * Adult male or female * Diagnosis of either oropharyngeal or supraglottic squamous cell carcinoma Exclusion Criteria: * Metastatic disease
References
Publications (0)
Data not yet available
No reference posted for this study.